Focus

P21-Adamantane.

Available Variants

10 mg

View lab reports Quality process

Research area: Focus

🛡️

For research purposes only. Not intended for use in humans or animals.

Neuroscience research

About P21-Adamantane

P21-Adamantane is studied in the context of neuroscience and cognitive research. Identical to the mechanism described for P021/P21 (CNTF-loop mimicry, BDNF-mediated GSK-3β inhibition); the adamantane group serves to increase lipophilicity and CNS penetration.

Research Application

Described in secondary literature, like P21, as a preclinical tool in Alzheimer's models; no independent body of studies distinct from the parent compound could be identified.

Important to know

Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.

Content 10 mg

Form Lyophilized powder

Category Focus

Purity & Identity see lab reports →

Sequence / Structure Adamantan-konjugiertes CNTF-Loop-Peptidomimetikum. Hinweis: In der Handelsliteratur ist unklar, ob „P21" und „P21-Adamantan" zwei unterschiedliche Moleküle oder dieselbe (bereits adamantanhaltige) Originalverbindung P021 bezeichnen.

Regulatory Status Preclinical only; no published study data independently identifiable under this label as distinct from P21 were found.

Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.

Research Overview

Studies on neuroscience-related peptides are predominantly preclinical.

Specific study references will be added for this product. For current literature, independent research (e.g. via PubMed) is recommended.

Similar Peptides

Focus P21 View → Focus Cerebrolysin View → Focus Cortagen View →

Question about P21-Adamantane?

We reply personally – via email or Telegram.

✉️ Email ✈️ Telegram

← Back to overview